CESELLY YATES: Open Payments
NPI 1194347997 · CRESTVIEW, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$422 in 16 payments from 8 companies in 2025. Trend: 2023 $455 · 2024 $138 · 2025 $422
Food & beverage: $422
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 3 | $127 |
| Fresenius USA Marketing, Inc. | 5 | $118 |
| Calliditas Therapeutics US Inc. | 3 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| Vifor Pharma, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $18 |
| Apellis Pharmaceuticals, Inc. | 1 | $15 |
Products named: VELPHORO, Filspari, TARPEYO, Kerendia, FARXIGA, Veltassa, Ozempic.
Industry payments across FL — which companies pay providers there.
